Quadratus Lumborum Plain Block Versus Fascia Iliac Block

• Sponsor: Minia University (Other)
• Overall Status: Completed
• CT.gov ID: NCT05920265
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Arms: 3
• Actual Duration (Months): 19
• Patients Per Site Per Month: 3.2

Study Details

Study Description

Brief Summary

evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery

Condition or Disease	Intervention/Treatment	Phase
Post Operative Pain	Procedure: Quadratus Lumborum plain Block; Procedure: fascia iliaca block; Diagnostic Test: control group	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 60 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Outcomes Assessor)
• Primary Purpose: Prevention
• Official Title: Quadratus Lumborum Plain Block Versus Fascia Iliac Block in Hip Fracture
• Actual Study Start Date: Feb 1, 2021
• Actual Primary Completion Date: Jun 15, 2022
• Actual Study Completion Date: Sep 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Quadratus Lumborum Block	Procedure: Quadratus Lumborum plain Block; ultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% .
Experimental: Fascia Iliac Block	Procedure: fascia iliaca block; ultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25%
Active Comparator: control	Diagnostic Test: control group; no intervention

Outcome Measures

Primary Outcome Measures

1. analgesic consumption [24 hour]

   intraoperative and post operative

Secondary Outcome Measures

1. Visual analogue pain score [24 hour]

   score 0-10 which mean 0 no pain and 10 the worst pain

2. first analgesic demand [24 hour]

   the first time to intake rescue analgesia

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 70 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• 18-70 years

• fracture hip

Exclusion Criteria:

• patients refuse

• mental problem patient with any coagulation deficiency or bleeding problems patient with allergy to investigated medications,

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Minia University	Minya	Minia	Egypt	61511

Sponsors and Collaborators

• Minia University

Investigators

• Study Director: abeer M hassaneen, Ass. professor, minia university hospital/ faculty of medicine
• Study Chair: ahmed H Mohamed, Professor, minia university hospital/ faculty of medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hassan Mokhtar Elshorbagy Hetta, lecturer of anesthesia and ICU, Minia University
• ClinicalTrials.gov Identifier: NCT05920265
• Other Study ID Numbers: 16:2021
• First Posted: Jun 27, 2023
• Last Update Posted: Jun 27, 2023
• Last Verified: Jun 1, 2023

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Hassan Mokhtar Elshorbagy Hetta, lecturer of anesthesia and ICU, Minia University: QLB; Fascia Iliac Block; hip surgery
• Additional relevant MeSH terms: Pain, Postoperative

Study Results

No Results Posted as of Jun 27, 2023